Issue link: https://beckershealthcare.uberflip.com/i/1242960
27 DEVICES & IMPLANTS Kevin Lobo's 8+ years as Stryker CEO: Leading 20+ acquisitions, boosting robotics & more By Alan Condon I n 2012, 18 months aer Kevin Lobo joined Stryker as group president of orthopedics, the company appointed him as CEO. Here are 10 things to know about Mr. Lobo: 1. Mr. Lobo has more than 24 years of expe- rience, holding several executive positions in general management and finance. Before en- tering the medical device industry, he worked for KPMG, Unilever and Kra Canada. 2. His net worth is estimated at $48.6 million, according to Wallmine. Mr. Lobo owns more than $5.75 million of Stryker stock and makes a $13.9 million salary. 3. Prior to Stryker, Mr. Lobo spent eight years at Johnson & Johnson, where he served as president of Johnson & Johnson Medical Canada and president of Ethicon Endo Sur- gery. While at Johnson & Johnson, he also op- erated as CFO of McNeil Consumer Health- care and Ortho Women's Health and Urology. 4. During his tenure as Stryker CEO, he spear- headed more than 20 acquisitions, including Mako Surgical, K2M, Trauson Holdings and Mobius Imaging. 5. Trauson Holdings, China's largest manu- facturer of pelvic reconstruction plates, was the first acquisition Mr. Lobo led. Stryker ac- quired the company in a $764 million all-cash transaction in 2013. 6. Stryker spent $1.65 billion to acquire Mako Surgical that same year. Four years later, the company launched the robotic-arm assisted total knee replacement application for use with the Mako System. 7. Additionally, Mr. Lobo serves as a board member for Parker Hannifin Corp., Ad- vanced Medical Technology Association, Business Leaders for Michigan and United Way. 8. Mr. Lobo was born in Mumbai, India, be- fore his family moved to Canada, where he grew up. He is fluent in English, French and speaks some Konkani and Hindi. 9. He graduated with a bachelor's degree in commerce from McGill University in Mon- treal, Canada, and a master's in business from the University of Toronto. 10. Mr. Lobo's goals for this year are to accel- erate Stryker's spine program and focus on spinal robotics aer the $500 million acqui- sition of Mobius and its subsidiary Cardan Robotics in October 2019. n Zimmer Biomet asks European hospitals to remove orthopedic spacer molds By Alan Condon Z immer Biomet on March 10 issued an urgent field safety notice to European hospitals request- ing the removal of the company's StageOne and StageOne Select bone cement spacer molds. The notice aimed to prevent the use of some implants, which may have been improperly cleaned and moni- tored. Zimmer Biomet received five complaints that may be linked to the issue, which could result in an adverse local tissue reaction, pains and potential reactions to allergens or toxins. More than 230,000 implants have been distributed. n Centinel Spine founder leaves to grow other business; Steven Murray named CEO By Eric Oliver Centinel Spine has a new CEO in Steven Murray, who joined the company March 16. What you should know: 1. Former CEO John Viscogliosi stepped down from the company to focus on his other company, Viscogliosi Broth- ers, which focuses on the neuromusculoskeletal segment of healthcare. 2. Mr. Viscogliosi founded Centinel over a decade ago. On his tenure, he said: "I am proud of the more than 200,000 patients who have been helped by our various technology platforms. The foundation has been laid for continued success and Ste- ven is the right leader to take the company forward." 3. Mr. Murray comes to Centinel after a tenure as the president of advanced sterilization products at Johnson & Johnson. He has more than 25 years of experience in orthopedics and 20 years of experience in an executive role. n